amikacin therapi exacerb pseudomona aeruginosa infect patient cystic fibrosi amikacin new semisynthet aminoglycosid antibiot activ pseudomona aeruginosa use treat 22 acut exacerb chronic pulmonari infect 18 patient cystic fibrosi patient rang 5 32 year age mucoid p aeruginosa isol sputum amikacin dose usual 75 mgkg everi eight hour increas 10 mgkg andor carbenicillin ad select case depend clinic cours although p aeruginosa elimin patient sputum except two case good clinic respons 19 22 cours signific improv chest xray film spirometri arteri oxygen tension document 11 17 cours one instanc serum creatinin level elev could attribut antibiot two patient show minim 15 db unilater highfrequ hear loss serial audiogram activ mani gentamicinresist strain high blood level among attract properti amikacin amikacin clinic effect treat pseudomonasassoci pulmonari infect complic cystic fibrosi